We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current AGRX market cap is 942k. The company's latest EPS is USD -5.7584 and P/E is -0.10.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 749k | 4.1M | 10.88M | 19.59M |
| Operating Income | -18.86M | -49.05M | -71.01M | -41.43M | -19.88M |
| Net Income | -18.61M | -51.85M | -74.89M | -25.41M | -14.47M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 49.54M | 73.06M | 39.33M | 14.24M | 10.26M |
| Total Liabilities | 3.8M | 23.73M | 30.06M | 19.79M | 26.57M |
| Total Equity | 45.75M | 49.33M | 9.27M | -5.55M | -16.32M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.69M | -47.31M | -65.2M | -35.95M | -9.58M |
| Investing | -98k | -40.69M | 39.46M | -133k | N/A |
| Financing | 42.42M | 67.99M | 30.42M | 22.18M | 6.89M |
| Market Cap | 942k |
| Price to Earnings Ratio | -0.10 |
| Price to Sales Ratio | 0.08 |
| Price to Cash Ratio | 0.59 |
| Price to Book Ratio | -0.09 |
| Dividend Yield | - |
| Shares Outstanding | 2.51M |
| Average Volume (1 week) | 30.74k |
| Average Volume (1 Month) | 50.82k |
| 52 Week Change | 56.58% |
| 52 Week High | 0.486 |
| 52 Week Low | 0.20 |
| Spread (Intraday) | 0.04 (9%) |
| Company Name | Agile Therapeutics Inc (PK) |
| Address |
1111b s governors ave dover, delaware 19904 |
| Website | https://www.agiletherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
